SODIUM ACETATE
Generic: SODIUM ACETATE
Fresenius Kabi USAManufacturer
INTRAVENOUSRoute
SODIUM ACETATEActive Substance
2017-10-30Original Approval
SODIUM ACETATE is FDA application ANDA206687, sponsored by FRESENIUS KABI USA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class I2022-03-04
Sodium Acetate Injection, USP, 400 mEq / 100 mL (4 mEq / mL), packaged in 2 trays of 20 vials per shipper (NDC 63323-032Presence of particulate matter: particulates composed of carbon and oxygen with varying amounts of i
Class II2013-02-26
Sodium Acetate Injection, USP, 40 mEq/20 ml (2 mEq/mL) 20 mL Single-Dose Fliptop, Rx only, HOSPIRA, INC. LAKE FOREST, ILLack of Assurance of Sterility: Loose crimp applied to the fliptop vial.
Top Reported Reactions
1
OFF LABEL USE
29 reports
2
PYREXIA
23 reports
3
NAUSEA
18 reports
4
DIARRHOEA
17 reports
5
DYSPNOEA
16 reports
6
PNEUMONIA
16 reports
7
VOMITING
16 reports
8
DEATH
15 reports
9
ANAEMIA
14 reports
10
CONDITION AGGRAVATED
13 reports